Association of Resistin with BMI, Age, Diabetes and Breast Cancer Biomarkers
Received Date: Feb 04, 2019 / Accepted Date: Feb 19, 2019 / Published Date: Feb 25, 2019
Breast cancer is the most often observed worldwide as the second cause of cancer-related death in women. High resistin level is associated with breast cancer, therefore it is considered as a breast cancer biomarker. For a real data set, the article shows that mean resistin is positively associated with monocyte chemoattractant protein-1 (MCP-1) (p<0.0001), types of patients (p<0.0001), interaction effect of Body Mass Index (BMI) and leptin (BMI*Leptin) (p=0.0415), Homeostasis Model Assessment Score (HOMA)*Age (p=0.1059), Adiponectin (p=0.1111), while it is negatively associated with HOMA (p=0.0698), Age (p=0.1249), Leptin*Adiponectin (p=0.0736), Glucose*Adiponectin (p=0.1007). Variance of resistin is positively associated with class of patients (p=0.0114) and BMI (p=0.0942). Some partially significant effects (around 15% level of significance) are included in the models treated as confounder according to Epidemiology. It is concluded that resistin is higher for younger women with breast cancer, higher levels of MCP-1, adiponectin, and higher interaction effects of BMI*Leptin, Age*HOMA.
Keywords: Adiponectin; BMI; Breast cancer; Leptin; MCP-1; Resistin; Non-constant variance
Citation: Das RN, Lee Y (2019) Association of Resistin with BMI, Age, Diabetes and Breast Cancer Biomarkers. J Oncol Res Treat 4: 135.
Copyright: © 2019 Das RN, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
- Total views: 1113
- [From(publication date): 0-0 - Apr 12, 2021]
- Breakdown by view type
- HTML page views: 1023
- PDF downloads: 90